Senior insider sale
Chief Scientific Officer at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$2.33M
75.78K shares
LILLIE JAMES WOODRUFF plans to sell 75.78K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $2.33M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
Restricted Stock Unit Grant
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/18/2025 | Restricted Stock Unit Grant N/A | 25.80K | — |
5/2/2024 | Restricted Stock Unit Grant N/A | 6.15K | — |
11/9/2023 | Restricted Stock Unit Grant N/A | 1.43K | — |
7/30/2023 | Restricted Stock Unit Grant N/A | 3.20K | — |
| Total | 36.58K | ||
Completed
Units to sell
721.00
Market value
$20.4K
Units to sell
24.81K
Market value
$713.7K
Units to sell
11.10K
Market value
$312.8K
Units to sell
15.80K
Market value
$441.8K
Units to sell
2.78K
Market value
$76.2K
Units to sell
1.73K
Market value
$46.4K
Planned — Approximate Date
Units to sell
18.84K
Market value
$714.0K
Units
75.78K
Value
$2.33M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/7/2026 | 721.00 | $20.4K | — | Completed |
5/6/2026 | 24.81K | $713.7K | — | Completed |
5/5/2026 | 11.10K | $312.8K | — | Completed |
5/4/2026 | 15.80K | $441.8K | — | Completed |
4/16/2026 | 2.78K | $76.2K | — | Completed |
4/15/2026 | 1.73K | $46.4K | — | Completed |
| Planned — Approximate Date | ||||
7/15/2026 | 18.84K | $714.0K | NASDAQ | Planned |
| Total | 75.78K | $2.33M | ||